title: Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors.
authors.affiliation: Division of Immunology and Organ Transplantation, University of Texas-Houston, Houston, Texas, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Langer
authors.forename: D M
authors.initials: DM
authors.lastname: Hong
authors.forename: S M
authors.initials: SM
authors.lastname: Katz
authors.forename: C T
authors.initials: CT
authors.lastname: Van Buren
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000077552:Basiliximab; D002784:Cholesterol / Q000097:blood; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005006:Ethnicity; D005260:Female; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000145:classification / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D019520:Living Donors; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins; D012189:Retrospective Studies; D020123:Sirolimus / Q000627:therapeutic use*; D013781:Texas
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D016572:Cyclosporine; D002784:Cholesterol; D000077552:Basiliximab; D003404:Creatinine; D011241:Prednisone; D020123:Sirolimus